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Previous studies have linked psychological morbidity to poor control of asthma, but have not objectively measured
adherence to treatment, and have linked poor adherence to depression, but have not measured asthma severity.
This study assessed asthma and psychological morbidity and objectively measured adherence to medication and
showed that psychological morbidity in those with asthma is significantly increased when control of asthma is poor,
especially when control is poor and adherence to inhaled steroid regimen is low.
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The association between asthma and psychological factors
has been observed for centuries (1) and a psychological
component to treatment was common from the 1930s to the
1960s. As a greater understanding of the pathology
developed, the emphasis moved to pharmacotherapy.
The 1970s and 1980s saw an increase in prevalence,
morbidity and mortality from asthma in England and
Wales (2), despite advances in drug treatment. Studies of
asthma fatalities initially focused on disease variables and
failures of care but have increasingly (3,4) commented on
factors such as ‘poor family functioning’, ‘depression’,
‘poor doctor–patient relationships’ and ‘social diculties’
as being contributory to the adverse outcome, and there has
been renewed interest in the relationship between ‘psycho-
social factors’ and disease.
Psychiatric morbidity has been examined at all levels of
severity of asthma in both adults and children, and higher
rates of psychiatric disorder compared to non-asthmatic
populations have been reported (5,6). Co-morbid psychia-
tric disorder has been linked to more severe disease (7),
increased length of stay in hospital (8) and increased use of
steroid medication (9).
Inability to adhere to a treatment regimen is often seen as
an important behavioural pathway through which many
psychosocial risk factors impact on asthma morbidity. The
aim of this study was to firstly assess asthma morbidity,Received 4 September 2000 and accepted 15 September 2000.
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ventative medication in an outpatient population, and
secondly (in preparation) to assess the usefulness of a
psychological intervention in those patients with severe
asthma who were poorly adherent to their inhaler regimens.
Method
Patients between 18 and 65 years with a clinical diagnosis of
asthma requiring inhaled steroids were recruited from
outpatient clinics at Guy’s, St Thomas’ and Lewisham
Hospitals, U.K. Asthma morbidity was scored using a
system described by Woolcock (10) to assess asthma
severity when patients are not experiencing an exacerba-
tion. The score is derived from the following information
collected over a 2-week period: self-report of symptoms and
use of reliever, measurement of peakflow variability and use
of emergency facilities. A cut-off point along the total of
scores given for each component classified patients as
having mild, moderate or severe asthma.
Patients with severe asthma had their adherence with
medication assessed. Adherence was objectively measured
using a microchip concealed in the back of the steroid
inhaler. Diskhalers containing disks of beclometasone
dipropionate were used and were supplied by Glaxo-
Wellcome. Patients not already using diskhalers were
changed from their current steroid to the equivalent dose
of beclometasone for the duration of the study. The
microchip stored information which could be later down-
loaded on to a computer giving the day and time the
inhalers were activated. Activation was triggered by open-
ing the diskhaler suciently to pierce the steroid blister.# 2001 HARCOURT PUBLISHERS LTD
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defined as taking over 70% of prescribed doses. The
background and ethics of using concealed monitoring to
measure adherence are discussed by Levine (11).
Psychological assessment was by the Hospital Anxiety
and Depression Scale (12) (HADS) and diagnostic inter-
view. The HADS is a 14-item self-report questionnaire
designed to detect psychological morbidity in a medically ill
population. There is a sub-scale for depression and anxiety.
A score above 8 on either sub-scale is said to screen for
possible disorder and above 11, a disorder is said to be
probable. Where a score of 8 was reached in either sub-
scale, patients were invited to a diagnostic interview. A
shortened version of the Structured Clinical Interview for
DSMIIIR, patient edition was used (13).
Patients were withdrawn from the study if they were felt
to need urgent psychiatric treatment or if becodisks were
considered by their physician to be unsuitable. Patients
were divided into the following four groups and character-
istics between the groups compared: group 1, those with
asthma which was well controlled (adherence not assessed);
group 2, those with poorly-controlled asthma who were
adherent with medication; group 3, those with poorly-
controlled asthma who were non-adherent with medication;
group 4, patients who were withdrawn or who dropped out.
ANALYSIS
Differences between the groups were analysed using one-
way variance analysis (ANOVA) with Bonferroni post hoc
testing. The differences in the sex ratios were analysed using
the w2-test.
ETHICS
This study was given ethical approval by Guy’s and St
Thomas’ Ethics Committee.
Results
The results are presented in Table 1. Using one-way
ANOVA analysis the differences in total HADS scoresTABLE 1. Demographic and psychological data of sub-groups
Group Number Age* % male Anxiety{ Depr
1 21 42 28?6 7?0
2 35 48?5 48?6 8?2
3 31 38?8 35?5 10?5
4 16 33?6 6?3 10?2
Total 103 41?9 34 9?0
*Age is given in mean years;
{ anxiety and depression are the mean scores on the Hospital A
{ the number of patients diagnosed with disorder at interview;
} the number who have had previous contact with psychiatric s
} either the total number or the average figure for the total grobetween these groups is significant with an overall P-value
50?002. This was also true when the two sub-scales
(anxiety and depression) were tested separately. Post hoc
testing showed group 1 to be different from 3 and 4 and
group 2 from 3.
Differences in the demographic compositions of groups
were also significant (P¼ 0?028). The group which were
adherent to their medication were significantly older and
contained more men. The drop-out group were significantly
younger and more likely to be female.
Sixty-two of the 103 patients scored above 8 on either
sub-scale and 44 (70%) of these were interviewed. Out of
the 19 patients with depression, five were receiving
treatment from their GP’s and 11 were co-morbid, also
having an anxiety disorder. So 31 patients (30%) were
found at interview to have a psychiatric disorder.
Discussion
In this study the HADS scores suggested probable
psychiatric disorder in 47 (46%) patients and on interview
31 (30%) were found to have a psychiatric disorder. Levels
of psychiatric disorder are comparable with other studies
(5,7) in asthma that record prevalence rates of 30–50%.
Other studies (14) have also found that a younger age is
more associated with poor adherence and non-attendance
in asthma management programmes.
The ratio of depressive disorder to anxiety disorder was
higher than in studies (15,7) where separate diagnoses were
recorded. Two factors could contribute to this. Firstly only
70% of those called to interview attended and those least
likely to attend for interview were the patients with good
control of their asthma who were not taking further part in
study. So those patients with higher psychiatric morbidity
were more likely to be interviewed.
Secondly it could be that this study was disproportio-
nately taken up by those in the clinic who were depressed.
The most common reason given for not wanting to take
part in the present study was feeling unable to commit to
weekly counselling sessions if eventually randomized to this
and the author’s impression was that those who were mostession{ Total
HADS{
No. with
anxiety{
No. with
depression{
Previous
contact}
3?2 10?2 1 0 0
5?2 13?4 6 1 5
6?5 17?0 13 12 7
6?9 17?1 3 6 2
5?5 14?4 23 19 11
nxiety and Depression Scale;
ervices;
up.
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distressed. A study on adherence (16) in this department
undertaken 2 years previously, recruiting from the same
outpatient clinic but without offering a psychological
intervention, found mean anxiety scores 8?3 (this study
8?9) and depression scores 4?0 (this study 5?5), P¼ 0?009.
What is highlighted by these figures is the distribution of
psychological morbidity. The population most at risk—those
who were poorly controlled and poorly adherent to their
medication and those who dropped out from clinic and/or
the study—had the highest psychiatric morbidity. Those with
asthma that was well-controlled had significantly less
psychiatric morbidity. Interestingly, the group with severe
asthma but good adherence showed a level of psychiatric
morbidity inbetween the highest and lowest levels.
The distribution of those diagnosed with depression at
interview was the most striking feature of the results. Only
one patient out of 19 was adherent to their medication. This
patient described at interview how her daughter felt a need
to supervise her medication as she herself could not be
relied upon to take it.
Several authors have reviewed the possible mechanisms
of interaction between anxiety, depression and asthma.
Wright (17) suggests that recent advances in the under-
standing of interactions between the central nervous
system, immune and endocrine function provide plausible
biological pathways linking psychosocial stress with asthma
expression.
This study demonstrates that behaviour in the form of
poor asthma self-management is clearly an important
pathway between psychological and physical distress and
suggests that treatment of psychological disorder may have
therapeutic benefits if adherence to inhaled steroid im-
proves alongside an improvement in psychological dis-
order. A study in diabetics with depression (18) suggested
that treating depression could improve glycaemic control
and a study in patients with multiple sclerosis (19) found
treating co-morbid depression to improve adherence to
interferon.
A recent (20) randomized controlled trial of stress
management with asthmatic children demonstrated psy-
chological and health gain but did not assess adherence to
medication. A next useful line of research would be to
examine the impact on asthma severity and adherence to
medication if psychological co-morbidity, especially depres-
sion, were treated.
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